|
HNRNPH3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.12300000304688E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.825500E-04 |
| Normal-vs-Stage2 |
1.116150E-03 |
| Normal-vs-Stage3 |
4.70400385310654E-11 |
| Normal-vs-Stage4 |
3.06970004970708E-10 |
| Stage1-vs-Stage2 |
3.075800E-01 |
| Stage1-vs-Stage3 |
2.25659999999461E-05 |
| Stage1-vs-Stage4 |
2.42669999999112E-05 |
| Stage2-vs-Stage3 |
1.015250E-01 |
| Stage2-vs-Stage4 |
9.763900E-02 |
| Stage3-vs-Stage4 |
9.365800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.07539999630413E-08 |
| Normal-vs-AfricanAmerican |
4.407200E-04 |
| Normal-vs-Asian |
6.701600E-01 |
| Caucasian-vs-AfricanAmerican |
7.154800E-01 |
| Caucasian-vs-Asian |
1.308180E-01 |
| AfricanAmerican-vs-Asian |
2.334600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.15200018600137E-10 |
| Normal-vs-Female |
3.026500E-04 |
| Male-vs-Female |
3.317700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.002800E-03 |
| Normal-vs-Age(41-60Yrs) |
2.27349999999404E-05 |
| Normal-vs-Age(61-80Yrs) |
5.44059997054092E-09 |
| Normal-vs-Age(81-100Yrs) |
1.421090E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.542000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.247200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.107600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.989590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.646770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.908600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.125600E-01 |
| Normal-vs-Grade 2 |
4.118800E-03 |
| Normal-vs-Grade 3 |
4.05789957191871E-10 |
| Normal-vs-Grade 4 |
1.96489491344209E-11 |
| Grade 1-vs-Grade 2 |
5.594200E-02 |
| Grade 1-vs-Grade 3 |
3.56420000002799E-06 |
| Grade 1-vs-Grade 4 |
1.46300000003485E-06 |
| Grade 2-vs-Grade 3 |
1.01309999944732E-07 |
| Grade 2-vs-Grade 4 |
3.28879999900167E-08 |
| Grade 3-vs-Grade 4 |
6.172500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.969800E-02 |
| Normal-vs-ccB subtype |
1.64379621026001E-12 |
| ccA subtype-vs-ccB subtype |
1.765254609154E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.603800000755E-08 |
| Normal-vs-N1 |
5.50759999999872E-05 |
| N0-vs-N1 |
8.939800E-02 |
|
|
